CSF-1/CSF-1R is the essential signaling pathway for macrophage survival and proliferation, but the CSF-1R inhibitor BLZ945 suppresses glioma growth and progression by altering macrophage polarization, but not by depleting macrophages 104, and improves the survival rate of glioma mice 105. This evidence concerns the gene CSF1R and central nervous system cancer.